Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 11 Jan 2022 for Applied Therapeutics Inc.. Read the official filing
Filing timeline
BuySaleCharles Silberstein
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Charles Silberstein: trading record in brief
Charles Silberstein (finance chief) discloses dealings in Applied Therapeutics Inc. to SEC (Form 4). Over a trading history stretching from 8 June 2021 to 7 January 2022, the count stands at 4 filings.
Every open-market trade on record is a sale: 1 sale worth €89k. Outside the open market, there are 3 share grants.
The record was last updated on 11 January 2022 with a share grant in Applied Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles Silberstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
47,900 shares0Common StockSEC:0001209191-22-002967:0
47,900 shares0Common StockSEC:0001209191-22-002971:0
47,900 shares0Common StockSEC:0001209191-21-070085:0
5,047 shares@ US$21.42100.0% of flowCommon StockSEC:0001209191-21-039723:0
4 of 4 declarations
